Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,21 CAD | -.--% | -.--% | +50,00% |
05/04 | PharmAla Biotech geeft Australische update | MT |
27/03 | Pharmala Biotech Holdings Inc. Toelating verleend voor Ala-002 Samenstelling door US Patent and Trademark Office | CI |
Lopende maand | +20,00% | ||
1 maand | +20,00% | ||
3 maanden | -10,64% | ||
6 maanden | +35,48% | ||
Lopend jaar | +50,00% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Nick Kadysh
CEO | Chief Executive Officer | 38 | 21-03-21 |
Carmelo Marrelli
DFI | Director of Finance/CFO | 53 | 22-03-21 |
Harpreet Kaur
CTO | Chief Tech/Sci/R&D Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Kevin Roy
BRD | Director/Board Member | - | 04-06-22 |
Director/Board Member | 62 | 21-03-21 | |
Jodi Butts
CHM | Chairman | 51 | 21-03-21 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+50,00% | 13,28 mln. | |
-3,46% | 102 mld. | |
+1,41% | 96,09 mld. | |
+2,13% | 22,28 mld. | |
-15,84% | 21,4 mld. | |
-9,16% | 18,14 mld. | |
-39,98% | 17,02 mld. | |
-14,65% | 16,09 mld. | |
+4,39% | 13,83 mld. | |
+31,35% | 11,97 mld. |